Traxis Partners’s Allergan Inc AGN Stock Holding History

Traxis Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-25,000	Closed	-$2.11M	–	61
2013 Q2	$2.11M	Buy	+25,000	New	+$2.59M	1.63%	32

Other funds holding AGN

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Traxis Partners's AGN Position: Q3 2013 in Review

Traxis Partners sold out of Allergan Inc (AGN) in Q3 2013, closing a stake of 25,000 shares — an estimated $2.11M sold.

Traxis Partners first reported a position in AGN in Q2 2013 and held it in 1 quarter. The position peaked at $2.11M in Q2 2013. 642 funds tracked by Wall St. Rank hold AGN as of Q3 2013.

Traxis Partners reported no remaining Allergan Inc position as of Q3 2013 after selling out during the quarter.
Traxis Partners sold 25,000 Allergan Inc shares in Q3 2013, an estimated $2.11M.
Traxis Partners first reported a position in Allergan Inc in Q2 2013 and held it in 1 quarter.
Traxis Partners's Allergan Inc position peaked at $2.11M in Q2 2013.
642 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2013.

Based on Traxis Partners's 13F filing for Q3 2013.